Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 5
2018 1
2019 1
2020 2
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
TACkling Cancer by Targeting Selective Protein Degradation.
Noblejas-López MDM, Tébar-García D, López-Rosa R, Alcaraz-Sanabria A, Cristóbal-Cueto P, Pinedo-Serrano A, Rivas-García L, Galán-Moya EM. Noblejas-López MDM, et al. Among authors: alcaraz sanabria a. Pharmaceutics. 2023 Oct 10;15(10):2442. doi: 10.3390/pharmaceutics15102442. Pharmaceutics. 2023. PMID: 37896202 Free PMC article. Review.
Transcriptome evolution from breast epithelial cells to basal-like tumors.
Santpere G, Alcaráz-Sanabria A, Corrales-Sánchez V, Pandiella A, Győrffy B, Ocaña A. Santpere G, et al. Among authors: alcaraz sanabria a. Oncotarget. 2017 Dec 8;9(1):453-463. doi: 10.18632/oncotarget.23065. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416627 Free PMC article.
Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast Cancer.
Fuentes-Antrás J, Alcaraz-Sanabria AL, Morafraile EC, Noblejas-López MDM, Galán-Moya EM, Baliu-Pique M, López-Cade I, García-Barberán V, Pérez-Segura P, Manzano A, Pandiella A, Győrffy B, Ocaña A. Fuentes-Antrás J, et al. Among authors: alcaraz sanabria al. Cancers (Basel). 2021 Feb 17;13(4):833. doi: 10.3390/cancers13040833. Cancers (Basel). 2021. PMID: 33671201 Free PMC article.
Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.
Pérez-Peña J, Alcaraz-Sanabria A, Nieto-Jiménez C, Páez R, Corrales-Sánchez V, Serrano-Oviedo L, Wali VB, Patwardhan GA, Amir E, Győrffy B, Pandiella A, Ocaña A. Pérez-Peña J, et al. Among authors: alcaraz sanabria a. Oncotarget. 2017 Mar 28;8(13):21733-21740. doi: 10.18632/oncotarget.15562. Oncotarget. 2017. PMID: 28423514 Free PMC article.
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
Nieto-Jimenez C, Alcaraz-Sanabria A, Martinez-Canales S, Corrales-Sanchez V, Montero JC, Burgos M, Nuncia-Cantarero M, Pandiella A, Galan-Moya EM, Ocaña A. Nieto-Jimenez C, et al. Among authors: alcaraz sanabria a. Int J Mol Sci. 2020 Nov 27;21(23):9034. doi: 10.3390/ijms21239034. Int J Mol Sci. 2020. PMID: 33261142 Free PMC article.
Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors.
Nieto-Jiménez C, Alcaraz-Sanabria A, Pérez-Peña J, Corrales-Sánchez V, Serrano-Heras G, Galán-Moya EM, Serrano-Oviedo L, Montero JC, Burgos M, Llopis J, Pandiella A, Ocaña A. Nieto-Jiménez C, et al. Among authors: alcaraz sanabria a. Oncotarget. 2017 Mar 21;8(12):19478-19490. doi: 10.18632/oncotarget.14465. Oncotarget. 2017. PMID: 28061448 Free PMC article.
11 results